SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-037450
Filing Date
2016-08-15
Accepted
2016-08-15 15:29:32
Documents
56
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q atrn20160810_10q.htm 10-Q 715241
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 18864
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 20063
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 10278
  Complete submission text file 0001437749-16-037450.txt   4365485

Data Files

Seq Description Document Type Size
5 EXHIBIT 101.INS atrn-20160630.xml EX-101.INS 679859
6 EXHIBIT 101.SCH atrn-20160630.xsd EX-101.SCH 52026
7 EXHIBIT 101.CAL atrn-20160630_cal.xml EX-101.CAL 25540
8 EXHIBIT 101.DEF atrn-20160630_def.xml EX-101.DEF 452886
9 EXHIBIT 101.LAB atrn-20160630_lab.xml EX-101.LAB 311763
10 EXHIBIT 101.PRE atrn-20160630_pre.xml EX-101.PRE 452315
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-51353 | Film No.: 161832256
SIC: 7389 Services-Business Services, NEC